Protheragen Secures Drug Distribution Registration in New Jersey

Leading supplier of active pharmaceutical ingredients (API) and specialty chemicals worldwide, Protheragen announces that we have received our official Drug Registration from the NJ Department of Health.

Per New Jersey regulations, any company that distributes prescription drugs, over-the-counter drugs, or both must register with the Department of Health. Registration ensures Protheragen is in compliance with NJAC 8: 21-3A, a regulation designed to protect public health by guaranteeing storage, handling and distribution of drugs meets strict standards.

"Adding New Jersey to our list of licenses expands our ability to support our partners. Ensuring a safe, compliant supply chain is our top priority," said a Protheragen representative. "This registration allows us to better serve our customers in a world-class life sciences hub."

Drug Ingredients for Wholesale Distribution

Obtaining wholesale distributor status allows Protheragen to legally buy and sell drug ingredients, whereas a mere logistics provider would never take title to the product. This is important for customers to know, as it ensures they are working with a company that follows strict record keeping and safety standards set forth by the state.

This latest achievement reflects Protheragen's proactive approach to regulatory excellence as it continues to grow its presence as a trusted partner in the global pharmaceutical industry. Please contact us today to discuss your needs.